Gabapentin Capsule
Product Images NDC 71335-2053

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 71335-2053). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Gabapentin-equation (Gabapentin Equation)

A text panel showing the formula for calculating creatinine clearance (CLCr), which involves age, weight, serum creatinine, and an adjustment factor for female patients.*

FDA Label Image

Gabapentin-fig1 (Gabapentin Fig1)

A line graph comparing mean pain scores over 8 weeks between placebo and gabapentin 3600 mg/day. The x-axis shows weeks from baseline to week 8, and the y-axis shows mean pain scores from 0 to 10. The graph includes a 4-week dose titration period and a 4-week fixed dose period.*

FDA Label Image

Gabapentin-fig2 (Gabapentin Fig2)

A line graph depicting mean pain scores over a 7-week period comparing Placebo, Gabapentin 1800 mg/day, and Gabapentin 2400 mg/day groups. The x-axis represents weeks from baseline to week 7, and the y-axis represents the mean pain score ranging from 0 to 10. The graph highlights a 3-week dose titration period followed by a 4-week fixed dose period.*

FDA Label Image

Gabapentin-fig3 (Gabapentin Fig3)

Bar chart titled 'Proportion of Responders (patients with ≥ 50% reduction in pain score) at Endpoint: Controlled PHN Studies' comparing placebo (PBO) and Gabapentin (GBP) doses. Study 1 shows 12% for placebo and 29% for GBP 3600 mg. Study 2 shows 14% placebo, 32% GBP 1800 mg, and 34% GBP 2400 mg responders with statistical significance indicated by asterisks.*

FDA Label Image

Gabapentin-fig4.jpg (Gabapentin Fig4)

A scatter plot chart showing percentage difference on the y-axis versus daily dose in milligrams on the x-axis. The chart compares three studies labeled 'STUDY a', 'STUDY b', and 'STUDY c' with data points at daily doses of approximately 600 mg, 900 mg, 1200 mg, and 1800 mg. Study 'a' is represented by black squares, Study 'b' by gray squares, and Study 'c' by white squares.*

FDA Label Image

Label (Lbl713352053)

Label for Gabapentin 100 mg Capsules, packaged by Bryant Ranch Prepack in Burbank, CA. The label states it is a human prescription drug, compares to Neurontin 100 mg Capsules from Alkem Laboratories, and indicates a package count of 90 capsules. Storage instructions include keeping at 20°-25°C and out of reach of children. The NDC is 71335-2053.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.